amounts of Cys or GSH to the serum and urine samples was in
general from 91% to 109%, which suggested the potential of the
present method for thiol determination in practical applications.
Moreover, we compared fluorescence intensity ratios between the
Sys (or GSH) calibration curve and the serum or urine samples
(with original plus spiked Cys or GSH), as shown in Fig. S13 and
S14 (ESIw; and one can see that for each specific concentration,
the two values are close to each other, further indicating that the
sensor can be used in thiol detection for biological samples.
The cytotoxicity of PyT–Hg(II)–TPy was evaluated using the
L929 cell line by an MTT assay. Hg2+ ion shows a Grade-IV
toxicity, the highest grade according to United States
Pharmacopoeia and ISO 10993–5 (Fig. S15, ESIw); while the
PyT–Hg(II)–TPy shows a Grade-I toxicity, indicating that the
complex’s toxicity is much lower. Theses results demonstrate
that the sensor herein may possess potential for detecting
thiols in biological fluids in vitro.
4 (a) X. Chen, S. K. Ko, M. J. Kim, I. Shin and J. Yoon, Chem.
Commun., 2010, 46, 2751; (b) M. Hu, J. Fan, H. Li, K. Song,
S. Wang, G. Cheng and X. Peng, Org. Biomol. Chem., 2011, 9, 980;
(c) W. Lin, L. Yuan, Z. Cao, Y. Feng and L. Long, Chem.–Eur. J.,
2009, 15, 5096; (d) H. Li, J. Fan, J. Wang, M. Tian, J. Du, S. Sun,
P. Sun and X. Peng, Chem. Commun., 2009, 5904.
5 (a) H. Xu and M. Hepel, Anal. Chem., 2011, 83, 813; (b) B. Han,
J. Yuan and E. Wang, Anal. Chem., 2009, 81, 5569; (c) J. S. Lee,
P. A. Ulmann, M. S. Han and C. A. Mirkin, Nano Lett., 2008,
8, 529; (d) Y. Zhang, Y. Li and X. Yan, Anal. Chem., 2009, 81,
5001–5007; (e) L. Shang, J. Yin, J. Li, L. Jin and S. Dong, Biosens.
Bioelectron., 2009, 25, 269–274.
6 (a) K. S. Lee, T. K. Kim, J. H. Lee, H. J. Kim and J. I. Hong,
Chem. Commun., 2008, 6173; (b) C. Yu, M. Luo, F. Zeng, F. Zheng
and S. Wu, Chem. Commun., 2011, 47, 9086.
7 (a) Z. Huang, F. Pu, Y. Lin, J. Ren and X. Qu, Chem. Commun.,
2011, 47, 3487; (b) J. V. Ros-Lis, B. Garci, D. Jimenez,
R. Martinez-Manez, F. Sancenon, J. Soto, F. Gonzalvo and
M. C. Valldecabres, J. Am. Chem. Soc., 2004, 126, 4064–4065.
8 (a) G. L. Law, R. Pal, L. O. Palsson, D. Parker and K. L. Wong,
Chem. Commun., 2009, 7321; (b) J. Chen, F. Zeng, S. Wu, J. Zhao,
Q. Chen and Z. Tong, Chem. Commun., 2008, 5580.
To further study the practical applicability of the sensor, we
investigated the effect of pH on the fluorescence response of
this system. As shown in Fig. S16 (ESIw), the fluorescence
intensity ratio I378 : I473 of PyT has no significant change from
pH 2.6 to pH 7.4. At pH below 5.0, upon addition of 5 mM
Hg2+, the intensity ratio I378 : I473 remained steady, and the
PyT–Hg(II)–TPy complex could not form. At pH above
5.8 and in the presence of mercury ions, PyT readily formed
the PyT–Hg(II)–Tpy complex. Upon addition of GSH to the
PyT–Hg(II)–TPy solution, the intensity ratio I378 : I473 recovers
in the pH range of 5.8–8.4. Therefore, this system could serve
as a ratiometric sensor of thiols in the pH range of 5.8–8.4.
In summary, a fluorescent ratiometric sensing system for
biothiols was successfully developed through a facile approach
based on the monomer–excimer transformation of pyrene
moieties. For this approach, the difference in the binding
affinity between thymine–Hg(II) and biothiol–Hg(II) was employed
to realize the detection. This excimer–monomer emission change
affords the PyT–Hg(II)–PyT, a reversible and sensitive fluorescent
ratiometric sensor for biothiols. Due to the existence of a hydro-
philic thymine moiety, this sensor can be used for biothiol
detection not only in HEPES buffered aqueous solution, but also
in urine and serum; and this ratiometric sensor exhibits a low
detection limit for GSH (69 nM). We suppose that the use of
unique binding properties of thymine and other nucleobases may
be applied in designing other sensors.
9 (a) B. Liu, F. Zeng, G. Wu and S. Wu, Chem. Commun., 2011,
47, 8913; (b) D. G. Smith, G. L. Law, B. S. Murray, R. Pal,
D. Parker and K. L. Wong, Chem. Commun., 2011, 47, 7347;
(c) H. Kashida, T. Takatsu, K. Sekiguchi and H. Asanuma,
Chem.–Eur. J., 2010, 16, 2479; (d) S. V. Wegner, A. Okesli,
P. Chen and C. He, J. Am. Chem. Soc., 2007, 129, 3474.
10 (a) B. Zhu, X. Zhang, Y. Li, P. Wang, H. Zhang and X. Zhuang,
Chem. Commun., 2010, 46, 5710; (b) L. Long, W. Lin, B. Chen,
W. Gao and L. Yuan, Chem. Commun., 2011, 47, 893;
(c) X. Zhang, X. Ren, Q. H. Xu, K. P. Loh and Z. K. Chen,
Org. Lett., 2009, 11, 1257.
11 (a) C. S. Lim, G. Masanta, H. J. Kim, J. H. Han, H. M. Kim and
B. R. Cho, J. Am. Chem. Soc., 2011, 133, 11132; (b) L. Yuan,
W. Lin and Y. Yang, Chem. Commun., 2011, 47, 6275;
(c) G. J. Kim, K. Lee, H. Kwon and H. J. Kim, Org. Lett.,
2011, 13, 2799.
12 (a) C. Yu and V. W. W. Yam, Chem. Commun., 2009, 1347;
(b) Z. Xu, N. J. Singh, J. Lim, J. Pan, H. N. Kim, S. Park,
K. S. Kim and J. Yoon, J. Am. Chem. Soc., 2009, 131, 15528;
(c) P. Conlon, C. J. Yang, Y. Wu, Y. Chen, K. Martinez, Y. Kim,
N. Stevens, A. A. Marti, S. Jockusch, N. J. Turro and W. Tan,
J. Am. Chem. Soc., 2008, 130, 336; (d) Q. Dai, W. Liu, X. Zhuang,
J. Wu, H. Zhang and P. Wang, Anal. Chem., 2011, 83, 6559–6564.
13 (a) P. J. Hrdlicka, B. R. Babu, M. D. Sorensen and J. Wengel,
Chem. Commun., 2004, 1478; (b) B. Schazmann, N. Alhashimy and
D. Diamond, J. Am. Chem. Soc., 2006, 128, 8607; (c) H. J. Kim,
S. K. Kim, J. Y. Lee and J. S. Kim, J. Org. Chem., 2006, 71, 6611;
(d) E. Manandhar, J. H. Broome, J. Myrick, W. Lagrone,
P. J. Cragg and K. J. Wallace, Chem. Commun., 2011, 47,
8796–8798.
14 (a) Y. Tanaka, S. Oda, H. Yamaguchi, Y. Kondo, C. Kojima and
A. Ono, J. Am. Chem. Soc., 2007, 129, 244; (b) H. Torigoe, A. Ono
and T. Kozasa, Chem.–Eur. J., 2010, 16, 13218.
We gratefully acknowledge financial support from NSFC
(Project No. 21025415, 21174040 and 50973032).
15 P. D. Oram, X. Fang, Q. Fernando, P. Letkeman and
D. Letkeman, Chem. Res. Toxicol., 1996, 9, 709.
16 IUPAC Compendium of Chemical Terminology, ed. A. D. McNaught
and A. Wilkinson, 1997.
17 Chemosensors: Principles, Strategies, and Applications, ed.
B. Wang and E. V. Anslyn, John Wiley &Sons, Inc., Hoboken,
2011.
18 (a) B. S. Hetzel, Bull. W. H. O., 2002, 80, 340–425; (b) H. J. Perkin,
B. R. Brown and J. Lang, Can. Med. Assoc. J., 1934, 10, 365–368.
19 (a) S. Huang, Q. Xiao, R. Li, H. Guan, J. Liu, X. Liu, Z. He and
Y. Liu, Anal. Chim. Acta, 2009, 645, 73–78; (b) S. Melnyk,
M. Pogribna, I. Pogribny, R. J. Hine and S. J. James, J. Nutr.
Biochem., 1999, 10, 490–497; (c) W. G. Christen, U. A. Ajani,
R. J. Glynn and C. H. Hennekens, Arch. Intern. Med., 2000,
160, 422.
Notes and references
1 (a) X. Chen, Y. Zhou, X. Peng and J. Yoon, Chem. Soc. Rev., 2010,
39, 2120–2135; (b) S. Y. Zhang, C. N. Ong and H. M. Shen, Cancer
Lett. (Shannon, Irel.), 2004, 208, 143–153.
2 D. M. Townsend, K. D. Tew and H. Tapiero, Biomed. Pharmacother.,
2003, 57, 145–155.
3 (a) A. Burns, H. Ow and U. Wiesner, Chem. Soc. Rev., 2006,
35, 1028; (b) H. N. Kim, M. H. Lee, H. J. Kim, J. S. Kim and
J. Yoon, Chem. Soc. Rev., 2008, 37, 1465; (c) O. S. Wolfbeis,
J. Mater. Chem., 2005, 15, 2657; (d) E. M. Nolan and S. J. Lippard,
J. Am. Chem. Soc., 2007, 129, 5910.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 6007–6009 6009